文献速递头颈外科

黑人头颈癌患者结局差异相关的肿瘤分子差异

Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
PubMed 文献 · Head Neck · 2022-02-21

研究从癌症基因组图谱等来源获取非HPV相关头颈鳞癌患者的临床和多平台分子数据,比较非西班牙裔黑人(n=43)与白人(n=354)患者。黑人患者无进展生存期更差,肿瘤拷贝数畸变更大,SFRP1甲基化增加和miRNA介导的PRG4沉默与不良生存相关,PI3K/AkT/mTOR通路蛋白差异表达。结论认为分子差异可能部分解释生存差异。

要点

  • 黑人患者无进展生存期较白人患者更差。
  • 黑人患者肿瘤拷贝数畸变更大,SFRP1甲基化增加和miRNA介导的PRG4沉默与不良生存相关。
  • PI3K/AkT/mTOR通路蛋白在两组间差异表达。

核心结论

  • 黑人与白人患者肿瘤之间存在分子差异,可能部分解释生存差异,并可能为靶向治疗决策提供信息以实现公平结局。

研究设计与样本

  • 从癌症基因组图谱和其他已发表研究下载临床和多平台分子数据,使用多变量模型比较非西班牙裔黑人(n=43)与白人(n=354)非HPV相关肿瘤患者,并使用公开验证队列。

主要发现

  • 黑人患者无进展生存期较白人患者更差。
  • 黑人患者肿瘤拷贝数畸变更大。
  • SFRP1甲基化增加和miRNA介导的PRG4沉默与不良生存相关。
  • PI3K/AkT/mTOR通路蛋白差异表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous studies of head and neck squamous cell carcinoma (HNSCC) have demonstrated disparate outcomes by race and ethnicity. Beyond known associations with socioeconomic variables, whether these are also associated with differences in tumor molecular composition has thus far been poorly explored. METHODS: We downloaded clinical and multiplatform molecular data from The Cancer Genome Atlas and other published studies. These were compared between non-Hispanic Black (n = 43) and White (n = 354) patients with non-HPV-related tumors, using multivariable models. Publicly available validation cohorts were used. RESULTS: Black patients had poorer progression-free survival than White patients. Tumors of Black patients had greater copy number aberrations, and increased SFRP1 methylation and miRNA-mediated PRG4 silencing associated with poor survival. PI3K/AkT/mTOR pathway proteins were differentially expressed. CONCLUSIONS: There are molecular differences between tumors of Black and White patients that may partially account for differences in survival. These may inform targeted treatment decisions to achieve equitable outcomes.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Kim HAJ, Zeng PYF, Sorgini A, et al. Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer. Head Neck. 2022. PMID: 35187756. doi:10.1002/hed.27007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。